Reuters logo
BRIEF-Myriad announces GeneSight Psychotropic results from a large prospective trial in patients with major depressive disorder
November 2, 2017 / 11:44 AM / 16 days ago

BRIEF-Myriad announces GeneSight Psychotropic results from a large prospective trial in patients with major depressive disorder

Nov 2 (Reuters) - Myriad Genetics Inc

* Myriad announces GeneSight® Psychotropic results from a large prospective trial in patients with major depressive disorder

* ‍Assurex Health - Patients receiving genesight test achieved statistically significant improvement in both remission rates, response rates Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below